Navigation Links
Influenza Vaccination Rates Among Health Care Personnel Remain Well Below National Goal
Date:2/27/2008

r and to patients. Indeed, the Call to Action report cites resources suggesting that unvaccinated health care personnel can be a key cause of influenza outbreaks in health care settings. One example is a 65-person outbreak in a long-term care facility in which only one in 10 health care personnel was vaccinated against influenza -- resulting in hospitalizations and a few deaths.

Influenza can put a significant economic burden on employers and all workplace environments. Influenza outbreaks force employees to cover shifts and rearrange schedules, causing unnecessary stress. Conversely, fewer cases of influenza among staff mean fewer sick days and hospitalizations.

Four years ago, the CDC issued recommendations encouraging health care personnel vaccination; since then, however, vaccination rates have fluctuated and they remain unacceptably low. These rates have led NFID and its supporters to resume and build on previous public health efforts to increase influenza vaccination rates.

Best Practices Report: Strategies to Increase HCP Immunization Rates

The content of the report, "Immunizing Healthcare Personnel Against Influenza: A Report on Best Practices," was derived from a recent roundtable meeting involving representatives from several national organizations, including the American Medical Association, CDC, and The Joint Commission, to discuss the successes and challenges of immunization practices. These same groups, among others, also support NFID in its Call to Action report.

Programs developed by Virginia Mason Medical Center, St. Jude Children's Research Center, Kaiser Permanente of Northern California and Cleveland Clinic successfully increased influenza vaccination rates among health care personnel. While each case study reveals its successes, each also illustrates the discussions and obstacles that occurred during the process. The report also includes an extensive overview of state legislative and regulatory efforts to incre
'/>"/>

SOURCE National Foundation for Infectious Diseases
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
2. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
3. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
4. Childhood Influenza Immunization Coalition Encourages Vaccination Throughout the Influenza Season
5. Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials
6. Actress and Mother Jennifer Garner Kicks Off American Lung Associations Faces of Influenza Awareness Campaign, Encouraging Families to Get Vaccinated Against Influenza
7. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
8. AlphaVax Announces Results From Phase 1 Influenza Vaccine Clinical Trial
9. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
10. Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant
11. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
Post Your Comments:
*Name:
*Comment:
*Email: